Clinical Trial Update: A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC) [Phase 1, Phase 2]

View source ↗

Summary

This update reports results from a Phase I/II study of TRC105 in metastatic castration-resistant prostate cancer. The trial has completed and results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• TRC105 (carotuximab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer, Metastatic Castrate Resistant Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-02-13